By Business/Source
Currency:EUR
2023/FY
Stock NameRevenueRatio
Research & Development (R&D) of pharmaceutical products in order to market them in the future4.62M100.00%
By Country/Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
France4.62M100.00%